Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe

An article was recently published in the journal Cytotherapy emphasizing the concern on the new pharmaceutical legislation of the EU. With the current proposal specialized committee functions will be integrated to other regulatory bodies. This decision may further challenge innovation in Europe, particulary in the field of ATMPs. The article goes over the disadvantages of the new proposal and the requirements necessary to maintain proper development and regulation of ATMPs.